Bahez Gareb

Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice

Bahez Gareb, Gerard Dijkstra, Jos G. W. Kosterink et al. · International Journal of Pharmaceutics · 2018 · 33 citations

Gastrointestinal Pharmacology, Medicine, Gastroenterology +3

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process

Bahez Gareb, Silke Posthumus, Max Beugeling et al. · Pharmaceutics · 2019 · 21 citations · Full text

Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease

Bahez Gareb, Anko C. Eissens, Jos G. W. Kosterink et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2016 · 16 citations

Inflammation, Anti-inflammatory, Functional Gastrointestinal Disorder +8

Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer

Linette Trea Oosting, Katka Franke, Michael V. Martin et al. · Pharmaceutics · 2022 · 16 citations · Full text

Immunology, Immunoediting, Pathology +28

Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer

Jacoba van Zanten, Annelies Jorritsma‐Smit, Hans H. Westra et al. · Pharmaceutics · 2024 · 12 citations · Full text

Tissue Engineering, Neck Cancer, Engineering +21